Limiting smartphone use to treat primary headaches
Smartphone Use Restriction as Treatment of Primary Headache: a Randomized Controlled Clinical Trial
This study is testing if cutting back on smartphone use can help people with primary headaches feel better and need less medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | All India Institute of Medical Sciences Academic / other |
| Locations | 1 site (New Delhi, National Capital Territory of Delhi) |
| Trial ID | NCT06041997 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of smartphone use restriction on patients suffering from primary headaches. It aims to determine whether reducing smartphone usage can lead to decreased medication consumption and improved responsiveness to treatments. Participants will be categorized based on their smartphone usage and randomized into groups receiving either standard treatment or smartphone restriction. The study also seeks to explore the relationship between the type of smartphone use and headache severity, as well as develop an addiction score to identify patients who may benefit from limiting their smartphone use.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with primary headaches who frequently use smartphones.
Not a fit: Patients with secondary headaches or those who do not use smartphones may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological treatment option for patients with primary headaches.
How similar studies have performed: While the specific approach of smartphone restriction is novel, other studies have explored non-pharmacological interventions for headache management with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Patients ≥18 years of age
2. Diagnosis of primary headache as per the ICHD3Beta classification ("ICHD-3 The International Classification of Headache Disorders 3rd Edition" n.d.)
3. Willing and consenting to participate in the study.
Exclusion Criteria:
* 1\. Secondary headaches 2. Not consenting for participation or follow up
Where this trial is running
New Delhi, National Capital Territory of Delhi
- Deepti Vibha — New Delhi, National Capital Territory of Delhi, India (Recruiting)
Study contacts
- Principal investigator: Deepti Vibha — All India Institute of Medical Sciences
- Study coordinator: Deepti Vibha
- Email: deeptivibha@aiims.edu
- Phone: +911126594485
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.